Graham Foxon is the Managing Director at ReMAP Consulting, a specialist pricing, market access, and health economic consultancy in the global healthcare sector. With a Ph.D. in Neuropharmacology from Durham University and an MBA from Aston University, Graham has a wealth of experience in various companies such as Adelphi Values, Ferring Pharmaceuticals, IMS Consulting, KCL Enterprises, and Syngenix. At ReMAP Consulting, Graham leads the team in developing payer-focused solutions and enhancing market access effectiveness for pharmaceuticals and medical devices.
Sign up to view 1 direct report
Get started